We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
Sekisui Diagnostics

Download Mobile App




Nanomodified Surfaces Seal Leg Implants Against Infection

By HospiMedica International staff writers
Posted on 07 Apr 2011
An innovative study demonstrates that nanometer-sized Titanium (Ti) topographies can be useful in increasing skin density while reducing bacteria adhesion, thus improving the efficacy of transcutaneous Ti-based orthopedic implants.

Researchers at Brown University (Providence, RI, USA;) have developed two ways in which to modify the surface of Ti leg implants to promote skin cell growth, thereby creating a natural skin layer and sealing the gap where the device has been implanted into the body. More...
The first approach involves an electron beam of titanium coating fired at the implant abutment, creating a landscape of 20-nanometer mounds. These mounds imitate the contours of natural skin and trick skin cells into colonizing the surface and growing additional keratinocytes.

The second approach is an anodization process, which involves dipping the abutment into hydrofluoric (HF) acid and passing a jolt of electric current through it. This causes the Ti atoms on the abutment's surface to disperse and then regroup as hollow, tubular structures rising perpendicularly from the abutment's surface; as with the mounds, keratinocytes can then quickly colonize the nanotubular surface. In laboratory tests, the researchers reported nearly a doubling of skin cell density on the implant surface; within five days, the keratinocyte density reached the point at which an impermeable skin layer bridging the abutment and the body had been created.

To further promote skin cell growth around the implant, the researchers developed a synthetic molecular chain to bind fibroblast growth factor 2 (FGF-2)--a single-chain polypeptide that plays a significant role in the process of wound healing and angiogenesis--to the Ti surface, while maintaining the protein's keratotic ability. In vitro tests again showed the greatest density of skin cells on abutment surfaces using the nanomodified surfaces laced with FGF-2. Moreover, the nanomodified surfaces created more surface area for FGF-2 proteins than would be available on traditional implants. The study was published ahead of print on February 11, 2011, in the Journal of Biomedical Materials Research A.

"You need to close the area where the bacteria would enter the body, and that's where the skin is,” said lead author Thomas Webster, PhD, an associate professor of engineering and orthopedics at Brown University. "You definitely have a complete layer of skin; there's no more gap for the bacteria to go through.”

Since Ti is biocompatible, it is used extensively in medical applications, including surgical implements and implants. The Ti is often alloyed with about 4% aluminum (Al), or 6% Al and 4% vanadium. Titanium also has the inherent property to osseointegrate, enabling use in dental implants; this property is also useful for orthopedic implant applications, which benefit from titanium's lower modulus of elasticity to more closely match that of the bone. As a result, skeletal loads are more evenly shared between bone and implant, leading to a lower incidence of bone degradation due to stress shielding and periprosthetic bone fractures, which occur at the boundaries of orthopedic implants.

Related Links:
Brown University



Gold Member
12-Channel ECG
CM1200B
Radiology Monitor
MDNC-6121 Barco Nio Color 5.8MP
Medical Examination & Procedure Light
Vega 80
Monitor/Defibrillator
Zenix
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Artificial Intelligence

view channel
Image: Clinical LLM Performance Improves by >300% When Provided with High-Quality Real-World Evidence in New Precision Medicine Benchmark (Photo courtesy of Atropos Health)

New Benchmark Highlights Evidence Gaps in AI Responses to Clinical Questions

Many clinical decisions still rely on limited evidence, while most artificial intelligence benchmarks overlook the patient context that shapes real-world care. General large language models can also struggle... Read more

Point of Care

view channel
Image Credit: 123RF

Continuous Glucose Monitoring Identifies Cardiometabolic Risk in Adults Without Diabetes

Dysglycemia—abnormal blood glucose regulation—can fluctuate throughout the day and often escape conventional screening. Clinicians typically rely on fasting plasma glucose and hemoglobin A1c, which offer... Read more

Business

view channel
Image: LigaSure RAS Maryland, designed for the Valleylab FT10 platform on Hugo RAS, seals and cuts vessels, tissue, and lymphatics up to 7 mm in diameter (Photo courtesy of Medtronic)

Medtronic Receives FDA Clearance for Vessel-Sealing Instrument for Robotic Surgery

As robotic-assisted surgery expands across U.S. hospitals, teams increasingly seek energy instruments with the familiarity and performance of tools used in open and laparoscopic procedures.... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.